Search results for “Chronic Kidney Diseases” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 2,753 patents, we discovered top 360 key players by total patent application. Eli Lilly & Co., Akebia Therapeutics, Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 15.22% of the total patent filing.
Indiana, United States
Patent: 174
Massachusetts, United States
Patent: 125
Switzerland
Patent: 120
New Jersey, United States
Patent: 106
Rheinland-Pfalz, Germany
Patent: 92
California, United States
Patent: 77
Basel-Stadt, Switzerland
Patent: 70
New York, United States
Patent: 65
Texas, United States
Patent: 48
Massachusetts, United States
Patent: 45
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 103 patents, we discovered top 20 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, SCOHIA PHARMA, Inc., Phanes Therapeutics, Inc. are active in this area.
STARTUP
France
Patent: 30
STARTUP
Kanagawa-ken, Japan
Patent: 17
STARTUP
California, United States
Patent: 9
STARTUP
North Carolina, United States
Patent: 7
STARTUP
Oregon, United States
Patent: 6
STARTUP
California, United States
Patent: 6
STARTUP
Tokyo-to, Japan
Patent: 5
STARTUP
California, United States
Patent: 4
STARTUP
France
Patent: 3
STARTUP
Michigan, United States
Patent: 3
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,555 patents applied in the last 5 years. We discover 370 most active companies in this area. The fast-growing Akebia Therapeutics, Inc., AstraZeneca Pharmaceutical Co., Ltd., Eli Lilly & Co. take 9.32% of patent filing during this period.
Massachusetts, United States
Patent: 58
Jiangsu Sheng, China
Patent: 45
Indiana, United States
Patent: 42
Massachusetts, United States
Patent: 40
Cambridgeshire, United Kingdom
Patent: 32
New Jersey, United States
Patent: 30
New York, United States
Patent: 29
Switzerland
Patent: 27
Tokyo-to, Japan
Patent: 27
California, United States
Patent: 26
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,555 patents in last 5 years, we discover 275 new entrants. AstraZeneca Pharmaceutical Co., Ltd., Enanta Pharmaceuticals, Inc., Japan Tobacco, Inc. are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 45
Massachusetts, United States
Patent: 40
Tokyo-to, Japan
Patent: 27
Virginia, United States
Patent: 25
California, United States
Patent: 24
undefined undefined
Patent: 20
STARTUP
Kanagawa-ken, Japan
Patent: 17
Vaud, Switzerland
Patent: 15
Osaka-fu, Japan
Patent: 15
France
Patent: 14
Research Institutions
Order by:
Innovation Intensity
With the analysis among 545 patents, we discovered top 117 universities and scientific research institutions by total patent application. China Pharmaceutical University, Icahn School of Medicine at Mount Sinai, Tohoku University are dominant in this area. They take 16.88% of the total patent filing.
Jiangsu Sheng, China
Patent: 24
New York, United States
Patent: 24
Miyagi-ken, Japan
Patent: 21
Mazowieckie, Poland
Patent: 12
New York, United States
Patent: 11
Illinois, United States
Patent: 10
United States
Patent: 10
Connecticut, United States
Patent: 9
Shanghai Shi, China
Patent: 5
Indiana, United States
Patent: 5
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: